Background: Fructose-1,6-bisphosphatase deficiency is a rare inborn error of metabolism affecting gluconeogenesis with only sporadic reports on its molecular genetic basis.
Background
Fructose-1,6-bisphosphatase (FBP1) deficiency [OMIM: 229700], first described in 1970 [1] , is an inborn error of gluconeogenesis. Patients present with ketotic hypoglycemia and lactic acidosis triggered by catabolic episodes such as prolonged fasting and/or febrile infections [2] . Laboratory findings may include hyperalaninemia, hyperketonemia, an increased lactate/ pyruvate ratio, an elevated plasma concentration of uric acid, glyceroluria [2] , and pseudo-hypertriglyceridemia [3] .
FBP1 deficiency is generally believed to be very rare with an estimated incidence between 1 : 350,000 and <1 : 900,000 in the Dutch and French population, respectively [4, 5] ; but it may be more frequent in populations with a higher rate of consanguinity.
FBP1 deficiency is inherited in an autosomal recessive way. It is caused by mutations within the FBP1 gene (OMIM: 611570) which spans approx. 31 kb on chromosome 9q22.2-q22. 3 and consists of 8 exons [6] . To date, only a small number of mutations has been published and among them, c.959dupG has been reported to be the most common one in Caucasians but also in patients from Japan and China [5, [7] [8] [9] .
We report results of mutation analysis of our laboratory, describe how we have characterized a common exon 2 deletion detected in patients with Turkish or Armenian ethnic background, and provide PCR conditions for verification of this deletion which is otherwise not detectable by standard sequencing techniques. Finally, we show for the first time that MLPA analysis may play a useful role in the diagnosis of FBP1 deficiency.
Methods
Fourteen patients with FBP1 deficiency from 13 families with typical clinical and laboratory results were diagnosed in our laboratory between 2006 and 2014 (Table 1) . Not all of them had enzymatic studies performed but all parents gave their informed consent to search for the molecular basis of the disease of their children and to be investigated for their own carrier status. In all of them, all 8 exons and adjacent intronic segments of the FBP1 gene were amplified by PCR and sequenced according to standard Sanger techniques (primer sequences and PCR conditions available upon request). In those patients in whom we assumed a deletion of exon 2 (the first coding exon), we were able to generate a junction fragment with primers 5′-taaaggtttccgcgattcac-3′ (sn) and 5′-gaccatcctggccaacac-3′ (asn). Results of sequencing studies were compared to our FBP1 reference sequence NM_001127628.1. Nomenclature for the description of sequence variants follows the recommendations of the Human Genome Variation Society [10] . The bioinformatic tools Polyphen-2 [11] and Mutation Taster [12] were used to predict effects of sequence aberrations.
In those patients in whom the diagnosis of FBP1 deficiency was not confirmed by Sanger sequencing and the detection of 2 biallelic mutations within FBP1, MLPA analysis was performed. We used the reaction mixtures SALSA MLPA probemix P255-B1 ALDOB-FBP1 (MRC Holland, Amsterdam, The Netherlands) according to the manufacturer's recommendations. Acquired data were normalized with 3-5 control DNA samples isolated in our laboratory. Calculations were performed with the SeqPilot software for genetic analyses version 4.1.2 (JSI Medical Systems, Ettenheim, Germany). SNP array analysis was performed using the Genome-Wide Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA) evaluated by the Genotyping Console software version 4.1.
Results and discussion
Conventional Sanger sequencing analysis of all coding exons allowed the diagnosis of FBP1 deficiency in 9 out of Table 1 ). These patients were found to be homozygous or compound heterozygous for mutations within FBP1. Among them, we found two novel missense mutations, p.(Pro120Leu) and p.(Gly207Arg) in exons 4 and 6, respectively, each in single families. Each of these two amino acid positions are part of highly conserved stretches of amino acids. Polyphen-2 predicts both of these 2 missense mutations to be 'probably damaging' (score 1.00). Mutation Taster classifies them as 'disease-causing' (with probability scores of 0.99999999999648 and 0.999999999878082, resp.). To our knowledge, p.(Pro120Leu) has never been reported to databases before; according to the ExAC database, the p.(Gly207Arg) variant has been observed in 10 European (non-Finnish) individuals in the heterozygous state with an allele frequency of 0.0001498 [13] .
To date, only a limited number of FBP1 mutations has been detected worldwide; our study brings up the total number to 35 (Table 2 ). Only few mutations have been found that do not have the characteristics of a private mutation. Among them is c.959dupG, originally found in the Japanese population [14] that has also been detected in patients from Europe [5] and North America [7] , and recently also in patients from China [9] . Another example is c.841G > A which has been detected in several unrelated patients from Pakistan [3] but also, with a different haplotype, in patients from Turkey [this study]. Furthermore, c.685C > T has repeatedly been found in seemingly unrelated families from Morocco [5, 15] .
In two of our patients, #12 and #13, only one mutation was detected by conventional Sanger sequencing analysis, however, haplotype analysis in the parents of patient #13 already suggested a long range deletion of the paternal allele (detailed results not shown). Of note, in 3 consecutive unrelated patients, one from Armenia and two from Turkey, no PCR product could be generated for exon 2 of the FBP1 gene. This observation prompted us to further investigate these patients. This was of particular interest since earlier reports on mutations in FBP1 had speculated that deletions within exon 2 (which at that time was termed exon 1) are common in the Turkish population, although the authors were not able to further characterize them [7] . Since we assumed the presence of a long-range deletion in these 3 patients, extensive modification of primer pairs was performed with the aim to generate a PCR product of acceptable size to be visible on polyacrylamide gel electrophoresis and eventually allowed the successful generation of a junction fragment (Fig. 1) . All 3 patients in Fig. 1 Characterization of a common long-range deletion of the FBP1 gene. A junction fragment including a deletion in the range of exon 2 was generated from DNA of patient 1. The result of the sequencing reaction is shown. The novel deletion (indicated in red) comprises 26 bp of intron 1, another 24 bp of the untranslated region (5′-UTR) before the ATG initiation codon of exon 2, the entire coding region of 170 bp of exon 2 (blue), and another 5192 bp of intron 2. The bold black lines (indicated by the asterisks) describe the position of the MLPA probes for exon 2 used in this study whom exon 2 could not be amplified with standard primers were thus found to be homozygous for a large deletion spanning 5412 base pairs and including the entire coding sequence of exon 2 (c.-24-26_170 + 5192del). All these patients were seemingly homozygous for the following polymorphisms that are all known from databases and have also been detected in our lab Fig. S3 ). These results are compatible with our assumption that this mutation represents a founder mutation in the Armenian and Turkish population. We believe that this mutation plays quite an important role in that geographical area since, in addition to Herzog et al. [7] (see above) who supposed deletions in exon 2 in patients originating from Turkey, also Lebigot et al. [5] , in a most recent study, reported exon 2 deletions by gene dose assays in Turkish patients; again, no further details regarding its length and location were provided. Furthermore, a preliminary communication from Turkey reported a relatively high number of FBP1-deficient cases from this region and, again, mentioned poorly defined exon 2 deletions [16] . It may therefore be speculated that the deletion characterized in detail in this paper is the same deletion as originally mentioned by several authors [5, 7, 16] and it may be concluded that this deletion of exon 2 is a relatively common cause of FBP1 deficiency in patients of Turkish and Armenian origin. Patients with this ethnic background should primarily be screened for this deletion and Sanger sequencing is now possible when using specific primers that allow sequencing of a junction fragment. Such long-range deletions and other variations in copy number, particularly when present in the heterozygous state, may escape conventional sequencing techniques. Multiplex ligation-dependent probe amplification (MLPA), originally described in 2002 [17] , is increasingly used for the targeted screening for copy number variations and has recently become commercially available for the FBP1 gene. Therefore, we applied this method to the five patients in whom we had not arrived at a diagnosis with standard sequencing techniques. Patients #1 to #3 all showed the typical pattern of homozygosity for an exon 2 deletion (Fig. 2b) , thus, MLPA analysis was in accordance with our sequencing results. In patient #12, we found that MLPA for exon 8 was diminished to approximately 50 % of normal controls (Fig. 2c) . Therefore, heterozygosity for a longrange deletion was supposed, which was subsequently confirmed by SNP array analysis (Table 2) . In patient #13, heterozygosity for a deletion on the paternal allele was confirmed and we could show that the deletion affects all 8 exons (Fig. 2d) . Furthermore, we were able to demonstrate by SNP array analysis that the mutation in pt #13 affecting the entire FBP1 gene is not identical to the one reported by Asberg [18] who described a patient with a deletion of the entire FBP1 gene together with the neighboring FBP2 and ONPEP genes ( Table 2) .
